gadolinium has been researched along with methotrexate in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 6 (37.50) | 29.6817 |
| 2010's | 6 (37.50) | 24.3611 |
| 2020's | 2 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Charpentier, A; de Baere, T; di Paola, M; Shapeero, LG; Terrier, P; Vanel, D | 1 |
| Fairclough, DL; Fletcher, BD; Hanna, SL; Le, AH; Meyer, WH; Parham, DM | 1 |
| Evens, AM; Gartenhaus, RB; Gordon, LI; Lecane, P; Magda, D; Miller, RA; Nelson, J; Prachand, S; Singhal, S | 1 |
| Dietemann, JL; Koob, M | 1 |
| Barnett, GH; Bhatia, J; Deogaonkar, A; Ebrahim, Z; Elkassabany, NM; Farag, E; Ference, S; Lotto, M; Maurtua, M; Schubert, A | 1 |
| El-Kiki, HA; Emad, Y; Raafat, H; Ragab, Y; Rasker, JJ; Shaarawy, A | 1 |
| Ando, M; Fujiwara, Y; Goto, Y; Katsumata, N; Kouno, T; Nakai, S; Sasajima, Y; Shimizu, C; Yonemori, K | 1 |
| Boyes, SG; Kraft, SL; Rowe, MD; Thamm, DH | 1 |
| Kim, YZ; Lee, EH; Sung, KH | 1 |
| Abou Chahla, W; Jissendi-Tchofo, P; Lolli, V; Pruvo, JP; Soto Ares, G | 1 |
| Madhuri, R; Patra, S; Roy, E; Sharma, PK | 1 |
| Amoura, Z; Cohen Aubart, F; Dodet, P; Galanaud, D; Isabel, C; Maillart, E | 1 |
| Di Palma, G; Gioulis, M; Marsala, SZ; Pistacchi, M; Sanson, F | 1 |
| Baidya, A; He, Y; Li, YS; Lu, ST; Mei, H; Wu, B; Xu, D | 1 |
| Fan, Z; Ge, D; Han, J; Hou, Z; Huang, D; Jiang, B; Su, G; Tu, L; Xiang, S; Yang, Y; Zhao, Q; Zhu, Q | 1 |
| Bang, J; Han, SW; Jung, WY; Ko, Y; Lim, YJ; Seo, HM; Yi, JH; Yu, MY | 1 |
16 other study(ies) available for gadolinium and methotrexate
| Article | Year |
|---|---|
Osteosarcoma after chemotherapy: evaluation with contrast material-enhanced subtraction MR imaging.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Combined Modality Therapy; Contrast Media; Doxorubicin; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Methotrexate; Organometallic Compounds; Osteosarcoma; Pentetic Acid; Remission Induction; Subtraction Technique | 1992 |
Assessment of osteosarcoma response to preoperative chemotherapy using dynamic FLASH gadolinium-DTPA-enhanced magnetic resonance mapping.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Contrast Media; Doxorubicin; Female; Gadolinium; Gadolinium DTPA; Humans; Ifosfamide; Magnetic Resonance Imaging; Male; Methotrexate; Necrosis; Organometallic Compounds; Osteosarcoma; Pentetic Acid; Preoperative Care | 1992 |
Motexafin gadolinium generates reactive oxygen species and induces apoptosis in sensitive and highly resistant multiple myeloma cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Gadolinium; Glutathione; Humans; Metalloporphyrins; Methotrexate; Multiple Myeloma; Reactive Oxygen Species | 2005 |
[Meningeal carcinomatosis].
Topics: Adult; Antimetabolites, Antineoplastic; Brain; Brain Neoplasms; Carcinoma; Diagnosis, Differential; Female; Gadolinium; Humans; Hydrocephalus; Injections, Spinal; Magnetic Resonance Imaging; Meningeal Neoplasms; Methotrexate; Prognosis; Sensitivity and Specificity; Spinal Puncture; Tomography, X-Ray Computed | 2006 |
Perioperative complications of blood brain barrier disruption under general anesthesia: a retrospective review.
Topics: Adult; Anesthesia Recovery Period; Anesthesia, General; Antimetabolites, Antineoplastic; Blood-Brain Barrier; Carotid Arteries; Central Nervous System Neoplasms; Electrocardiography; Female; Gadolinium; Humans; Hypertonic Solutions; Infusions, Intra-Arterial; Intraoperative Complications; Lymphoma; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Postoperative Complications; Postoperative Nausea and Vomiting; Retrospective Studies; Seizures; Tachycardia; Tomography, X-Ray Computed; Vertebral Artery | 2008 |
Enhanced MRI in early undifferentiated oligoarthritis of the knee joints: improvements already visible after 2 months of DMARDs treatment.
Topics: Antirheumatic Agents; Arthritis; Gadolinium; Hydroxychloroquine; Image Enhancement; Knee Joint; Magnetic Resonance Imaging; Methotrexate; Time Factors | 2008 |
Leptomeningeal metastasis from ovarian carcinoma successfully treated by the intraventricular administration of methotrexate.
Topics: Antimetabolites, Antineoplastic; Female; Gadolinium; Humans; Injections, Intraventricular; Magnetic Resonance Imaging; Meningeal Neoplasms; Methotrexate; Middle Aged; Ovarian Neoplasms | 2008 |
Polymer-modified gadolinium metal-organic framework nanoparticles used as multifunctional nanomedicines for the targeted imaging and treatment of cancer.
Topics: Animals; Antimetabolites, Antineoplastic; Diagnostic Imaging; Dogs; Endothelium, Vascular; Gadolinium; Growth Inhibitors; Magnetic Resonance Imaging; Methotrexate; Nanomedicine; Nanoparticles; Polymers; Sarcoma | 2009 |
Factors influencing the response to high dose methotrexate-based vincristine and procarbazine combination chemotherapy for primary central nervous system lymphoma.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Contrast Media; Disease-Free Survival; DNA-Binding Proteins; Drug Administration Schedule; Female; Follow-Up Studies; Gadolinium; Humans; Interferon Regulatory Factors; Lymphoma; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Odds Ratio; Procarbazine; Prospective Studies; Recurrence; Regulatory Factor X Transcription Factors; Severity of Illness Index; Transcription Factors; Tumor Suppressor Protein p53; Vincristine; X-Box Binding Protein 1 | 2011 |
Chédiak-Higashi syndrome: brain MRI and MR spectroscopy manifestations.
Topics: Brain; Chediak-Higashi Syndrome; Child; Contrast Media; Cyclosporine; Dexamethasone; Diffusion Magnetic Resonance Imaging; Echo-Planar Imaging; Follow-Up Studies; Gadolinium; Humans; Image Enhancement; Immunosuppressive Agents; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Methotrexate; Recurrence; Treatment Outcome | 2015 |
Stimuli-responsive poly(N-isopropyl acrylamide)-co-tyrosine@gadolinium: Iron oxide nanoparticle-based nanotheranostic for cancer diagnosis and treatment.
Topics: Acrylic Resins; Antimetabolites, Antineoplastic; Biological Transport; Cell Line; Contrast Media; Drug Carriers; Drug Compounding; Drug Liberation; Ferric Compounds; Fibroblasts; Gadolinium; Humans; Hydrogen-Ion Concentration; Hyperthermia, Induced; Magnetic Fields; Magnets; MCF-7 Cells; Methotrexate; Nanoparticles; Organ Specificity; Temperature; Theranostic Nanomedicine; Tyrosine | 2016 |
Spinal Koebner phenomenon: Medullar sarcoidosis facing a discal hernia.
Topics: Adrenal Cortex Hormones; Biopsy, Needle; Cervical Vertebrae; Drug Therapy, Combination; Female; Follow-Up Studies; Gadolinium; Humans; Immunohistochemistry; Infliximab; Infusions, Intravenous; Intervertebral Disc Displacement; Magnetic Resonance Imaging; Methotrexate; Middle Aged; Paresis; Radiographic Image Enhancement; Sarcoidosis; Treatment Outcome | 2017 |
Primary central nervous system lymphoma in an immunocompetent patient: an unusual case of prolonged response to steroids.
Topics: Central Nervous System Neoplasms; Gadolinium; Humans; Immunocompetence; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Steroids | 2018 |
Evaluation of methotrexate-conjugated gadolinium(III) for cancer diagnosis and treatment.
Topics: Animals; Antimetabolites, Antineoplastic; Brain Neoplasms; Cell Proliferation; Cell Survival; Contrast Media; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Gadolinium; Glioma; Humans; Magnetic Resonance Imaging; Methotrexate; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Structure; Neoplasms, Experimental; Organometallic Compounds; Structure-Activity Relationship | 2018 |
Tumor-Specific Endogenous Fe
Topics: Animals; Antineoplastic Agents; Artesunate; Cell Line, Tumor; Cell Survival; Drug Carriers; Ferrous Compounds; Gadolinium; Humans; Hydrogen-Ion Concentration; Magnetic Resonance Imaging; Methotrexate; Mice; Mice, Nude; Nanoparticles; Neoplasms; Rats; Reactive Oxygen Species; Theranostic Nanomedicine; Xenograft Model Antitumor Assays | 2020 |
Late Onset Nephrogenic Systemic Fibrosis in a Patient with Stage 3 Chronic Kidney Disease: a Case Report.
Topics: Aged; Contrast Media; Dermatologic Agents; Disease Progression; Gadolinium; Glomerular Filtration Rate; Humans; Magnetic Resonance Imaging; Male; Methotrexate; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency, Chronic; Severity of Illness Index; Skin; Ultraviolet Therapy | 2020 |